The drug also is being investigated for Alzheimer’s disease psychosis.
Dr. Marsh disclosed that she had received honoraria from Roche Pharmaceuticals in 2013, and has received royalties from Taylor & Francis/Informa.
On Twitter @alz_gal
Conference Coverage
AAGP: Treating Parkinson’s psychosis takes balance on risk/benefit tightrope
